

Hikma lowers medium-term profit forecast due to injectables margin pressures *


(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reduced medium term guidance and cut the top-end of its 2025 core operating profit view amid a...


(Alliance News) - Stock prices in London opened steady on Thursday amid a delude of earnings, as investors focus on a finely balanced interest rate de...


(Sharecast News) - Drugmaker Hikma Pharmaceuticals lowered its medium-term margin expectations for its injectables division on Thursday, as part of it...


(Alliance News) - The FTSE 100 outperformed European and US peers on Tuesday, but sterling fell further, as Chancellor Rachel Reeves laid the groundwo...


(Alliance News) - The FTSE 100 hit another record peak on Friday fuelled by weaker-than-expected US inflation data, a bunch of optimistic UK economic ...


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: